Engineering Safer and More Effective Cell Therapies episode artwork

EPISODE · Dec 1, 2022 · 19 MIN

Engineering Safer and More Effective Cell Therapies

from The Bio Report · host Levine Media Group

Arcellx is developing controllable cell therapies for the treatment of cancer and autoimmune diseases. It’s platform technology allows it to mark diseased cells within the body for destruction. Its cell therapies then destroy the flagged cells. We spoke to Rami Elghandour, chairman and CEO of Arcellx, about the company’s platform technology, how it works, and how it may lead to safer and more effective cell therapies.

Arcellx is developing controllable cell therapies for the treatment of cancer and autoimmune diseases. It’s platform technology allows it to mark diseased cells within the body for destruction. Its cell therapies then destroy the flagged cells. We spoke to Rami Elghandour, chairman and CEO of Arcellx, about the company’s platform technology, how it works, and how it may lead to safer and more effective cell therapies.

NOW PLAYING

Engineering Safer and More Effective Cell Therapies

0:00 19:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Bio Report?

This episode is 19 minutes long.

When was this The Bio Report episode published?

This episode was published on December 1, 2022.

What is this episode about?

Arcellx is developing controllable cell therapies for the treatment of cancer and autoimmune diseases. It’s platform technology allows it to mark diseased cells within the body for destruction. Its cell therapies then destroy the flagged cells. We...

Can I download this The Bio Report episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!